Professor Ian Wilkinson
Prof Wilkinson is Director of the CCTU, Honorary Consultant Physician at Cambridge University Hospitals NHS Foundation Trust, WE Parkes British Heart Foundation Senior Fellow, fellow of the British Hypertension Society, fellow of the British Pharmacological society and fellow of the American Heart Association. He is also Professor of Therapeutics, Staff Fellow in Clinical Medicine, Director of the Office of Translational Research and Head of the Experimental Medicine and Immunotherapeutics (EMIT) group at the University of Cambridge. His research focuses on understanding the biological pathways underlying systemic hypertension and arteriosclerosis, with a strong emphasis on basic physiology, experimental/translational medicine and early phase interventional clinical trials.
Louise Stockley is the Operations Director of the CCTU. She directs the strategic research operations and administrative functions of the unit. She holds overall responsibility for ensuring that the CCTU portfolio of interventional and observational trials are well managed and demonstrate good value, innovation and excellence in health research.
Dr Simon Bond
Dr Bond is the Lead Senior Statistician at the CCTU. He leads the statistics department of the unit in the development and delivery of statistical services and maintains his own research portfolio of developments in statistical methodology. Dr Bond leads the Early Phase Clinical Trials Group within the NIHR statistics group, and leads an NIHR efficiency project that provides software tools to aid the reporting of safety data into EudraCT. He is a Chartered Statistician within the Royal Statistical Society and is an Associate Lecturer at the University of Cambridge.
Dr Rona Smith
Dr Smith is an Expert Advisor and Senior Clinical Trials Fellow at the CCTU and a Consultant Nephrologist at Cambridge University Hospitals NHS Foundation Trust. She is a Staff Fellow at Trinity College as well as a Clinical Lecturer in nephrology and experimental medicine at Cambridge University. Dr Smith leads a portfolio of trials in renal medicine and autoimmune diseases and consults as trials methodologist.
Carrie Bayliss is the Regulatory and Quality Manager of the CCTU. She has overall management responsibility for the Regulatory Team which undertakes Sponsor delegated functions for all clinical trials of investigational medicinal products, ensuring they are set up, conducted and completed in compliance with all local and national regulations and guidelines.
Dr Paula Kareclas
Dr Kareclas is the Clinical Trials Manager of the CCTU Core Theme and has overall management responsibility for a team of trial coordinators and data managers. She ensures that all clinical research projects managed by the Core Theme are set-up, ran and closed down in accordance with all Sponsor, funder and regulatory requirements.
Alfred Larbi is the Grants Officer at the CCTU and Interim Research Lead of the Patient Led Research Hub within the CCTU. He provides financial and methodological advice to researchers developing clinical research proposals, focused on a broad spectrum of treatment areas. He also supports the strategic operations and administrative functions of the unit.
Dr Thomas Hiemstra
Dr Hiemstra is a Lecturer in Clinical Trials at the University of Cambridge and an Honorary Consultant Nephrologist at Cambridge University Hospitals NHS Foundation Trust. He leads a portfolio of trials and cohort studies in renal medicine and related specialties and consults with prospective chief investigators as trials methodologist. Dr Hiemstra directs the Patient Led Research Hub, chairs the UK Kidney Research Consortium Clinical Trials Network (UKRTN), is chair of the International Clinical Trials Centre Network (ICN), and deputy chair of the International Society of Nephrology Advancing Clinical Trials (ISN-ACT).